About MicroSert

About company

MicroSert Ltd. is developing an intraocular implant for the treatment of chronic eye diseases such as AMD and DME. AMD and DME, both leading causes of blindness, are treated with monthly Intravitreal injections (insertion of a needle into the eye) of Lucentis or Avastin. Extremely non patient-friendly, involves safety issues and delivers a peak drug concentration.